A Randomised, Double-blind, Placebo-controlled, Proof-of-mechanism Phase 2 Trial Investigating the Effect of Quinagolide Extended-release Vaginal Ring on Reduction of Lesions Assessed by High-resolution Magnetic Resonance Imaging in Women With Endometrioma, Deep Infiltrating Endometriosis, and/or Adenomyosis
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 13 Feb 2019
At a glance
- Drugs Quinagolide (Primary)
- Indications Adenomyosis; Endometriosis
- Focus Therapeutic Use
- Acronyms QLARITY
- Sponsors Ferring Pharmaceuticals
- 04 Feb 2019 Planned End Date changed from 1 Nov 2020 to 1 Dec 2020.
- 04 Feb 2019 Planned primary completion date changed from 5 Oct 2020 to 1 Nov 2020.
- 19 Dec 2018 Planned initiation date changed from 1 Jan 2019 to 1 Feb 2019.